Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Zeitschrift Fur Rheumatologie|September 4, 2025
[Chimeric antigen receptor T-cells for patients with hematologic malignancies]Maria-Luisa Schubert, Peter Dreger, Michael Schmitt
Frontiers in Immunology|June 17, 2021
The Potential Role of the Intestinal Micromilieu and Individual Microbes in the Immunobiology of Chimeric Antigen Receptor T-Cell TherapyMaria-Luisa Schubert, Roman Rohrbach, Michael Schmitt, et al.
International Journal of Cancer|November 10, 2017
Chimeric antigen receptor transduced T cells: Tuning up for the next generationMaria-Luisa Schubert, Jean-Marc Hoffmann, Peter Dreger, et al.
Journal of Clinical Medicine|February 10, 2019
Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML)Susanne Hofmann, Maria-Luisa Schubert, Lei Wang, et al.
International Journal of Cancer|April 10, 2020
B-cell maturation antigen-specific chimeric antigen receptor T cells for multiple myeloma: Clinical experience and future perspectivesLeopold Sellner, Fuli Fan, Nicola Giesen, et al.
Frontiers in Immunology|December 3, 2024
GVHD after CAR T-cell therapy post allogeneic hematopoietic cell transplantation - successfully treated by extracorporeal photopheresisKiavasch Mohammad Nejad Farid, Gesine Bug, Anita Schmitt, et al.
Human Gene Therapy|August 2, 2016
Chimeric Antigen Receptor T Cell Therapy Targeting CD19-Positive Leukemia and Lymphoma in the Context of Stem Cell TransplantationMaria-Luisa Schubert, Angela Hückelhoven, Jean-Marc Hoffmann, et al.
Cancers|April 30, 2021
Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin LymphomaFelix Korell, Maria-Luisa Schubert, Tim Sauer, et al.
Annals of Hematology|December 3, 2020
Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world dataPatrick Derigs, Aleksandar Radujkovic, Maria-Luisa Schubert, et al.
Cells|May 21, 2020
Current Challenges in Providing Good Leukapheresis Products for Manufacturing of CAR-T Cells for Patients with Relapsed/Refractory NHL or ALLFelix Korell, Sascha Laier, Sandra Sauer, et al.
Pageof 5